Focused on advanced wound care, this sector manufactures synthetic skin substitutes, bioengineered grafts, and cellular therapies for trauma or chronic wound management. Increasing global injuries and diabetic ulcers propel market growth. Technologies emphasize biocompatibility, mechanical strength, and infection control. Key stakeholders include biotech startups and established medical manufacturers. High costs and regulatory barriers limit access. Still, ongoing innovations support faster healing processes, functional restoration, and patient comfort improvement, strengthening global healthcare delivery standards.